Taris Biomedical Liris

At Manningham Medical Centre, you can find all the data about Taris Biomedical Liris. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.

Allergan Acquires LiRIS Program From TARIS Biomedical

https://drug-dev.com/allergan-acquires-liris-program-from-taris-biomedical/

Allergan Inc. and TARIS Holdings LLC recently announced that Allergan has closed a transaction to acquire worldwide rights to TARIS Biomedical’s lead program, LiRIS, …

Allergan Buys Rights to TARIS’ LiRIS for Up to $587.5M

https://www.genengnews.com/topics/drug-discovery/allergan-buys-rights-to-taris-liris-for-up-to-587-5m/

Allergan Buys Rights to TARIS’ LiRIS for Up to $587.5M August 14, 2014 Allergan has acquired worldwide rights to TARIS Biomedical’s lead program LiRIS®, …

TARIS | Janssen

https://www.janssen.com/oncology/janssen-oncology-strengthens-disease-interception-focus-taris-unique-delivery-system

The TARIS system is a first-in-class clinical stage platform to evaluate novel, locally delivered therapeutics to patients with bladder cancer, and potentially other types …

Allergan Acquires LiRIS® Program from TARIS Biomedical®

https://www.fiercebiotech.com/biotech/allergan-acquires-liris%C2%AE-program-from-taris-biomedical%C2%AE

Allergan Acquires LiRIS® Program from TARIS Biomedical® | Fierce Biotech Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Research Biotech …

TARIS Biomedical | Flagship Pioneering

https://www.flagshippioneering.com/companies/taris-biomedical

TARIS®’s first program, LiRIS® (lidocaine releasing intravesical system), for the treatment of interstitial cystitis/bladder pain syndrome, was acquired by Allergan® in August of 2014. TARIS® has now turned its focus to …

Big step in battling bladder disease | MIT News

https://news.mit.edu/2014/startups-bladder-disease-medical-device-acquired-1016

Longtime collaborators, Institute Professor Robert Langer (left) and Cima, co-founded Taris Biomedical to commercialize the controlled-delivery devices. Credits. Photo: M. Scott Brauer. The millions …

Allergan Acquires LiRIS ® Program from TARIS Biomedical

https://www.businesswire.com/news/home/20140813006097/en/Allergan-Acquires-LiRIS%C2%AE-Program-from-TARIS-Biomedical%C2%AE

The TARIS Biomedical delivery platform is designed to improve treatment by providing controlled, sustained delivery of a drug directly to target tissues. The TARIS …

Overview of Taris GemRIS, a Novel Drug Delivery …

https://pubmed.ncbi.nlm.nih.gov/31561993/

GemRIS, an implantable drug delivery system from Taris Biomedical that delivers continuous intravesical gemcitabine, shows potential for use in multiple bladder …